Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-protein coupled receptor 101 (GPR101) is an orphan Class A G-protein coupled receptor that plays a critical role in growth hormone regulation, energy homeostasis, and inflammation resolution. It is highly expressed in the hypothalamus and pituitary gland, where it exhibits high constitutive activity, stimulating cyclic AMP (cAMP) production via Gs, Gq/11, and G12/13 pathways in the absence of ligands. Overexpression of GPR101, typically caused by microduplications on chromosome Xq26.3, is the primary driver of X-linked acrogigantism (X-LAG), a rare pediatric syndrome characterized by early-onset gigantism, pituitary hyperplasia, and excessive growth hormone and prolactin secretion. Beyond its endocrine functions, GPR101 acts as a high-affinity receptor for the specialized pro-resolving mediator resolvin D5 (RvD5n-3 DPA), regulating leukocyte phagocytosis and promoting the resolution of inflammation. While no FDA-approved drugs currently target GPR101, small-molecule agonists like AA-14 have shown potential in restoring growth hormone axis function and promoting rejuvenation, whereas inverse agonists are actively being researched to treat X-LAG by blocking the receptor's constitutive activity.
GPR101 is a constitutively active receptor that couples to Gs, Gq/11, and G12/13 pathways to stimulate cAMP production and intracellular signaling. Agonists like AA-14 and Resolvin D5 (RvD5n-3 DPA) bind to the receptor to activate downstream signaling pathways, while inverse agonists are sought to block its constitutive activity to treat X-linked acrogigantism.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein coupled receptor 101 (GPR101).